Sami Hamadé, Partner

Joined in 2006 with 16 years of experience founding, operating and investing in medical device companies
Founding and operating roles in the original multi-billion dollar stent and high-growth peripheral business at
Guidant Corporation
Led Guidant's corporate venture, business development and M&A group with investments in more than 25 companies
Academic affiliations with bio-innovation departments of both Stanford University and University of Michigan
Stanford MBA; MS Engineering, University of Michigan; BS Engineering, American University of Beirut

Current Aberdare Boards:

Autonomic Technologies, Cavu Medical, NxThera, Paracor Medical, Portaero, Sonitus

Select Former Boards / Investments:

Ablation Frontiers, Evalve, Cardiomems, Spiration, Cardica, CardioNet, Cryovascular

"Sami really understands how strategic investors and industry players think about the whole picture of investment opportunities. He has significant operation knowledge in medical devices, and understands the nuances of bringing a product through development to commercialization."
- Bob Paulson, CEO, NxThera

"Sami was an operating guy, so he knows the pain points of being a CEO – building, hiring and managing staff. When it comes to the business issues he can frame the questions on a board level that drives discussion and action that is right to the point." - Amir Abolfathi, CEO, Sonitus

"In an industry where there are lots of existing and replicating patterns, Sami both embraces and brings fresh ideas to the table. Sami's ability to see outside these patterns, and maintain an openness to the truly fresh ideas is distinct." - James Currier, Founder and Chairman, Jiff